For research use only. Not for use in humans.

Tanezumab (Anti-NGF / bNGF)

Synonyms: RN-624 Cat.No.A2679 Purity:99%

Tanezumab (Anti-NGF / bNGF) is a human IgG2 monoclonal antibody targeting nerve growth factor (NGF). It can be used in studies of acute and chronic pain such as osteoarthritis, knee and neuralgia, as well as post-herpetic neuralgia. MW :150 KD.

Quality Control

Batch: A267901 Purity: 99% Protein concentration: 10.651mg/ml Endotoxin Level: ＜1EU/mg

Cited in Nature Medicine for its top-tier quality
COA
SDS
Datasheet

Mechanism of Action

Description	Tanezumab (Anti-NGF / bNGF) is a human IgG2 monoclonal antibody targeting nerve growth factor (NGF). It can be used in studies of acute and chronic pain such as osteoarthritis, knee and neuralgia, as well as post-herpetic neuralgia. MW :150 KD.
References	[1] https://www.jpain.org/article/S1526-5900(09)00195-3/fulltext

Cell Lines	Assay Type	Concentration	Incubation Time	Formulation	Activity Description	PMID

Product Details

CAS No.	880266-57-9
Molecular Weight	150
Isotype	Human IgG1
Source	CHO
Purification	AKTA
Sterility	0.2 μM filtered
Formulation	100 mM Pro-Ac, 20mM Arg, pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

^*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.